Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 15, Issue 9, Pages 861-871
Publisher
Informa UK Limited
Online
2017-08-14
DOI
10.1080/14787210.2017.1367666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15)
- (2017) Michael A. Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa–infected patients
- (2016) William R. Judd et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model
- (2016) Yu-Wei Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
- (2016) Juan José Castón et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug resistant Pseudomonas aeruginosa survey in a stream receiving effluents from ineffective wastewater hospital plants
- (2016) Mary Joyce Targino Lopes Magalhães et al. BMC MICROBIOLOGY
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation
- (2016) S. J. Kaiser et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Outbreak of pulmonaryPseudomonas aeruginosaandStenotrophomonas maltophiliainfections related to contaminated bronchoscope suction valves, Lyon, France, 2014
- (2016) Marine Guy et al. Eurosurveillance
- What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
- (2016) Ivan Gentile et al. Expert Review of Anti-Infective Therapy
- Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections
- (2016) Matteo Bassetti et al. Expert Review of Anti-Infective Therapy
- Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes
- (2016) Anthony D. Harris et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Continuous infusion of β-lactam antibiotics for all critically ill patients?
- (2016) Fabio S. Taccone et al. INTENSIVE CARE MEDICINE
- Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation
- (2016) O. Asuphon et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients: Table 1.
- (2016) Silvia Corcione et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unit
- (2016) F. Tissot et al. JOURNAL OF HOSPITAL INFECTION
- Aminoglycosides: An Overview
- (2016) Kevin M. Krause et al. Cold Spring Harbor Perspectives in Medicine
- Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies
- (2016) Yu Zhang et al. Emerging Microbes & Infections
- Duration of antibiotic therapy in the intensive care unit
- (2016) Gabor Zilahi et al. Journal of Thoracic Disease
- Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
- (2016) Kellie Goodlet et al. Therapeutics and Clinical Risk Management
- Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014
- (2016) Lindsey M. Weiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
- (2015) Wesley D. Oliver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice
- (2015) Matthew J. Labreche et al. CLINICAL INFECTIOUS DISEASES
- Optimizing dosing of antibiotics in critically ill patients
- (2015) Suzanne L. Parker et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The increasing threat of Pseudomonas aeruginosa high-risk clones
- (2015) Antonio Oliver et al. DRUG RESISTANCE UPDATES
- Prevalence and risk factors associated with colonization and infection of extensively drug-resistantPseudomonas aeruginosa: a systematic review
- (2015) Michael Buhl et al. Expert Review of Anti-Infective Therapy
- Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice?
- (2015) Francesco Scaglione INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates
- (2015) Benjaporn Kunakonvichaya et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations
- (2015) Claire Roger et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin: How should It Be Dosed for the Critically Ill?
- (2015) Cornelia Landersdorfer et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
- (2014) Stijn I. Blot et al. ADVANCED DRUG DELIVERY REVIEWS
- Mutation-Driven β-Lactam Resistance Mechanisms among Contemporary Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates from U.S. Hospitals
- (2014) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
- (2014) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
- (2014) Gloria Wong et al. BMC INFECTIOUS DISEASES
- Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*
- (2014) Marin H. Kollef et al. CRITICAL CARE MEDICINE
- Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation
- (2014) Matteo Bassetti et al. Future Microbiology
- Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update
- (2014) Jean-Louis Vincent Future Microbiology
- Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study
- (2014) A.-G. Venier et al. JOURNAL OF HOSPITAL INFECTION
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
- (2013) Karri A. Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary: Combination Therapy for Pseudomonas aeruginosa Bacteremia: Where Do We Stand?
- (2013) Mical Paul et al. CLINICAL INFECTIOUS DISEASES
- Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
- (2013) Carmen Peña et al. CLINICAL INFECTIOUS DISEASES
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
- (2013) E. Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients*
- (2013) Stijn Blot et al. CRITICAL CARE MEDICINE
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
- (2013) George G. Zhanel et al. DRUGS
- Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality
- (2013) C. Peña et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
- (2013) Niteen D. Karnik et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical implications of antibiotic pharmacokinetic principles in the critically ill
- (2013) Andrew A. Udy et al. INTENSIVE CARE MEDICINE
- Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
- (2013) Mario Tumbarello et al. INTENSIVE CARE MEDICINE
- Pharmacokinetics of linezolid during extracorporeal membrane oxygenation
- (2013) Francesco G. De Rosa et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: A meta-analysis of retrospective and prospective studies
- (2013) Yangmin Hu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis
- (2013) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH
- (2013) Francesco G. De Rosa et al. JOURNAL OF CHEMOTHERAPY
- Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
- (2013) Wilhelmina G Melsen et al. LANCET INFECTIOUS DISEASES
- Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg
- (2012) E Szałek et al. Advances in Medical Sciences
- Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: First step toward initiating surveillance programs in a resource-limited country
- (2012) Amani El-Kholy et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
- (2012) Qin Lu et al. ANESTHESIOLOGY
- Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia
- (2012) Dana R. Bowers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock
- (2012) Fabio Silvio Taccone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
- (2012) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Introduction to Drug Pharmacokinetics in the Critically III Patient
- (2012) Brian S. Smith et al. CHEST
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility*
- (2012) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- ‘Old’ antibiotics for emerging multidrug-resistant bacteria
- (2012) Phillip J. Bergen et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Novel therapeutic strategies to counterPseudomonas aeruginosainfections
- (2012) Joanne L Fothergill et al. Expert Review of Anti-Infective Therapy
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- Health Care-Associated Pneumonia (HCAP)
- (2011) Scott T. Micek et al. MEDICINE
- Monotherapy or Combination Therapy? ThePseudomonas aeruginosaConundrum
- (2011) Kristi A Traugott et al. PHARMACOTHERAPY
- The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) Study: A Multicenter Study
- (2011) Raymond J Yost et al. PHARMACOTHERAPY
- Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa
- (2010) V. H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of multidrug-resistantPseudomonas aeruginosainfection on patient outcomes
- (2010) Elizabeth B Hirsch et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- Pharmacokinetic issues for antibiotics in the critically ill patient
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
- (2009) R. Maviglia et al. CURRENT DRUG TARGETS
- Nosocomial cross-transmission ofPseudomonas aeruginosabetween patients in a tertiary intensive care unit
- (2009) KashiN Prasad et al. Indian Journal of Pathology and Microbiology
- Imipenem Resistance in Pseudomonas aeruginosa Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
- (2009) Ebbing Lautenbach et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Update on the treatment of Pseudomonas aeruginosa pneumonia
- (2009) A. A. El Solh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now